PCI Pharma Services (PCI) has announced an expansion of its onsite cold chain storage capabilities at its Hay-on-Wye facility in the UK. The announcement is the latest in a series of strategic investments at PCI, […]
e-therapeutics has entered into a research collaboration with Danish drug manufacturer Novo Nordisk to discover biological mechanisms and therapies to treat type-2 diabetes. Under the agreement, the two companies will use e-therapeutics’ network-driven drug discovery […]
Bristol-Myers Squibb will evaluate Opdivo (nivolumab) in combination with Vedanta Biosciences’ VE800, a live biotherapeutic product (LBP), in patients with advanced or metastatic cancers. In this connection, the Bristol-Myers Squibb and Vedanta Biosciences, an affiliate of […]
Mallinckrodt plc, a leading global specialty pharmaceutical company, today announced plans to spin off a new company consisting of Mallinckrodt’sSpecialty Generics/Active Pharmaceutical Ingredients (Specialty Generics) business and AMITIZA (lubiprostone) to Mallinckrodt shareholders, subject to final Board approval. The separation is […]
Imperial College London and the Coalition for Epidemic Preparedness Innovations have formed a partnership to help protect against Disease X. The $8.4million project will develop technology to rapidly develop vaccines against known pathogens – such […]